PreCure ApS

PreCure ApS develops high-grade smart wearable technology and intelligent equipment, with the aim of reducing the extent of Musculoskeletal Disorders (MSD) among employees in private and public companies. By reducing MSD, the employees' mental and physical well-being improves, which results in the number of days of absence due to illness being reduced to the benefit of both employees and companies.

Financial review

The company's income statement for the year ended 31 December 2024 shows a loss of DKK 1.780.674, and the balance sheet at 31 December 2024 shows equity of DKK 1.087.299.…

Expected development of the company, including specific prerequisites and uncertainties

PreCure ApS expects an improved result in 2025 compared to 2024. This expectation is primarily based on the company's new distribution strategy as described above.

In recent years, the company has incurred significant development costs for the products MLI® Elbow and MLI® Back. In 2024, both products are considered to be fully developed and will be transitioned to commercial marketing. There has already been significant interest in the product, and significant sales and earnings from the product are expected. As a result of the company's activity, there is a natural uncertainty associated with the measurement of the company's development assets. The valuation is essentially dependent on the realization of expected sales and earnings.

In 2024, PreCure ApS had an agreement with a foreign partner for the distribution of the company's products. In 2025, PreCure ApS has entered into an agreement with this partner that the distribution agreement will terminate with effect from the second half of 2025, after which Precure ApS itself will be responsible for sales and distribution in these relevant markets. This agreement of termination of the cooperation agreement means that the PreCure ApS will lose future sales/earnings from the business partner in question. On the other hand, PreCure ApS – as mentioned in the above section – will have the opportunity for more direct access to the end customers, which the company considers to be of crucial importance for the future development of the company's sales.

The company has no contingent liabilities.

Fixtures and fittings, tools and equipment, intangible assets, receivalbes, stocks etc. has been deposited as security for the company mortgage for DKK 5,500 thousand. The carrying value of the mentioned assets charge totals DKK 1,046 thousand at 31 December 2024.